EA031758B1 - Ниацинамид для стимуляции продуцирования антимикробных пептидов - Google Patents

Ниацинамид для стимуляции продуцирования антимикробных пептидов Download PDF

Info

Publication number
EA031758B1
EA031758B1 EA201692284A EA201692284A EA031758B1 EA 031758 B1 EA031758 B1 EA 031758B1 EA 201692284 A EA201692284 A EA 201692284A EA 201692284 A EA201692284 A EA 201692284A EA 031758 B1 EA031758 B1 EA 031758B1
Authority
EA
Eurasian Patent Office
Prior art keywords
niacinamide
skin
antimicrobial peptides
coli
psoriasin
Prior art date
Application number
EA201692284A
Other languages
English (en)
Russian (ru)
Other versions
EA201692284A1 (ru
Inventor
Амитабха Маджумдар
Мрутхунджая Свами Матхапати
Бхарат Паланисами
Рамиа Сампатха Кумар
Джоти Кумар Тивари
Original Assignee
Юнилевер Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнилевер Н.В. filed Critical Юнилевер Н.В.
Publication of EA201692284A1 publication Critical patent/EA201692284A1/ru
Publication of EA031758B1 publication Critical patent/EA031758B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EA201692284A 2014-05-12 2014-05-12 Ниацинамид для стимуляции продуцирования антимикробных пептидов EA031758B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2014/059590 WO2015172801A1 (en) 2014-05-12 2014-05-12 Niacinamide for inducing generation of antimicrobial peptides

Publications (2)

Publication Number Publication Date
EA201692284A1 EA201692284A1 (ru) 2017-03-31
EA031758B1 true EA031758B1 (ru) 2019-02-28

Family

ID=50771476

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692284A EA031758B1 (ru) 2014-05-12 2014-05-12 Ниацинамид для стимуляции продуцирования антимикробных пептидов

Country Status (8)

Country Link
JP (1) JP6446065B2 (zh)
CN (2) CN106413680A (zh)
BR (1) BR112016024400A2 (zh)
EA (1) EA031758B1 (zh)
MX (1) MX2016014760A (zh)
PH (1) PH12016502047A1 (zh)
WO (1) WO2015172801A1 (zh)
ZA (1) ZA201607105B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118680840A (zh) 2015-08-10 2024-09-24 玫琳凯有限公司 局部用组合物
MX2018004143A (es) 2015-10-05 2018-06-13 Unilever Nv Composicion que comprende niacinamida y picolinamida.
JP6942725B2 (ja) * 2016-05-10 2021-09-29 ユニリーバー・ナームローゼ・ベンノートシヤープ 局所抗菌組成物
US10869862B2 (en) 2016-05-26 2020-12-22 Conopco, Inc. Antimicrobial compositions for topical use
WO2018218012A1 (en) * 2017-05-24 2018-11-29 Follea International Synephrine compositions
WO2019086327A1 (en) 2017-10-30 2019-05-09 Unilever N.V. Use of niacinamide for microbiome balancing
CN111491612B (zh) * 2017-12-18 2023-10-20 联合利华知识产权控股有限公司 局部组合物
CN111683649A (zh) * 2017-12-18 2020-09-18 荷兰联合利华有限公司 基于烟酰胺衍生物的局部组合物
EP3764975B1 (en) 2018-03-13 2021-10-13 Unilever Global IP Limited A sanitizer composition
WO2024042554A1 (en) * 2022-08-25 2024-02-29 Istituto Fondazione Di Oncologia Molecolare Ets A pharmaceutical composition for treatment of viral infections
WO2024041910A1 (en) * 2022-08-25 2024-02-29 Unilever Ip Holdings B.V. Inactivation or kill of virus and compositions thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026308B1 (en) * 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
WO2006040048A1 (en) * 2004-10-15 2006-04-20 Bayer Consumer Care Ag Acidic and buffered skin-care compositions comprising nicotinamid and an absorbing agent
WO2011133692A1 (en) * 2010-04-20 2011-10-27 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
WO2012049677A2 (en) * 2010-10-10 2012-04-19 Dermipsor Ltd. Compositions for treating psoriasis of the scalp
WO2012137169A1 (fr) * 2011-04-05 2012-10-11 L'oreal Nouvel actif pour prevenir ou traiter le cuir chevelu
DE102012002592A1 (de) * 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP)
EP2742942A1 (en) * 2012-12-14 2014-06-18 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
CN101019865A (zh) * 2007-01-23 2007-08-22 中国医学科学院皮肤病医院 抗炎、保湿、祛斑的复方烟酰胺药用组合物
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
EP2861229B1 (en) * 2012-06-15 2020-12-23 CONARIS research institute AG A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026308B1 (en) * 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
WO2006040048A1 (en) * 2004-10-15 2006-04-20 Bayer Consumer Care Ag Acidic and buffered skin-care compositions comprising nicotinamid and an absorbing agent
WO2011133692A1 (en) * 2010-04-20 2011-10-27 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
WO2012049677A2 (en) * 2010-10-10 2012-04-19 Dermipsor Ltd. Compositions for treating psoriasis of the scalp
WO2012137169A1 (fr) * 2011-04-05 2012-10-11 L'oreal Nouvel actif pour prevenir ou traiter le cuir chevelu
DE102012002592A1 (de) * 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP)
EP2742942A1 (en) * 2012-12-14 2014-06-18 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PIERRE KYME, NILS H. THOENNISSEN, CHING WEN TSENG, GABRIELA B. THOENNISSEN, ANDREA J. WOLF, KENICHI SHIMADA, UTZ O. KRUG, KUNIK LE: "C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice", JOURNAL OF CLINICAL INVESTIGATION, vol. 122, no. 9, 4 September 2012 (2012-09-04), pages 3316 - 3329, XP055128464, ISSN: 00219738, DOI: 10.1172/JCI62070 *
TATSUO HASHIMOTO, THOMAS PERLOT, ATEEQUR REHMAN, JEAN TRICHEREAU, HIROAKI ISHIGURO, MAGDALENA PAOLINO, VERENA SIGL, TOSHIKATSU HAN: "ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation", NATURE, �MACMILLAN JOURNALS LTD., ETC.|, vol. 487, no. 7408, 1 January 2012 (2012-01-01), pages 477 - 481, XP055059617, ISSN: 00280836, DOI: 10.1038/nature11228 *

Also Published As

Publication number Publication date
MX2016014760A (es) 2017-03-06
CN106413680A (zh) 2017-02-15
JP6446065B2 (ja) 2018-12-26
CN113908074A (zh) 2022-01-11
BR112016024400A2 (pt) 2017-08-15
ZA201607105B (en) 2018-05-30
EA201692284A1 (ru) 2017-03-31
PH12016502047A1 (en) 2017-01-09
JP2017515829A (ja) 2017-06-15
WO2015172801A1 (en) 2015-11-19

Similar Documents

Publication Publication Date Title
EA031758B1 (ru) Ниацинамид для стимуляции продуцирования антимикробных пептидов
EP2742942B1 (en) Niacinamide for inducing generation of antimicrobial peptides
JP5584833B2 (ja) 美容方法
KR101669359B1 (ko) 멜라닌 합성 촉진용 조성물
WO2019086327A1 (en) Use of niacinamide for microbiome balancing
ES2670646T3 (es) Utilización de un extracto de lino procedente de la hidrólisis de las proteínas de lino, como agente activo antimicrobiano
KR102173646B1 (ko) 피부 유래 스트렙토코쿠스 살리바리우스 ｓｂｋ４ 신균주 및 이를 이용한 기능성 화장료 조성물
EP3362038A1 (en) Cosmetic composition having probiotic bacteria
KR101634668B1 (ko) 겨우살이의 발효된 추출물을 포함하는 항산화 또는 미백용 화장료 조성물
KR101842700B1 (ko) 에델바이스 식물 세포 배양 추출물 및 천연 복합 추출물을 유효성분으로 포함하는 화장료 조성물
CN114369553A (zh) 一株抗炎的表皮葡萄球菌
BR112018010456B1 (pt) Composição antimicrobiana, método para limpeza ou desinfecção de uma superfície e usos de uma composição
KR102200874B1 (ko) 키토산을 유효성분으로 포함하는 피부상태 개선용 조성물 및 이의 제조방법
KR20220153866A (ko) 장미 유래 세포외소포체를 유효성분으로 포함하는 피부 개선용 외용제 조성물
KR101433823B1 (ko) 부챗말 추출물 또는 분획물을 이용한 피부 외용제 조성물
JPWO2020090321A1 (ja) 熱ショックタンパク質遺伝子発現調整剤、医薬品、化粧品、及び熱ショックタンパク質遺伝子発現調整剤の製造方法
KR20190111840A (ko) 피부 유래 유산균 및 그 배양물을 포함하는 화장료 조성물
JP2024525082A (ja) 局所スキンケア用の細菌株
KR102139000B1 (ko) 발효 식이유황 추출물을 함유하는 항산화, 항주름, 미백 및 항균 기능성 화장료 조성물 및 그 제조방법
RU2729821C1 (ru) Противомикробная смесь, содержащая 4-(3-этокси-4-гидроксифенил)бутан-2-он и хлорфенезин, и косметическая композиция, содержащая ее
CN114096229A (zh) 双脱水己糖醇用于消除痤疮、头皮屑和异味对仪容仪表的影响的用途
JP7503503B2 (ja) 炎症性成分を有する皮膚または粘膜の罹患を予防および処置するための化合物
CN105310917A (zh) 一种防晒抗过敏性水性剂
AU2021105081A4 (en) Design and analysis of various formulations of selected herbo cosmeceuticals
KR102715941B1 (ko) 동물 세포의 세포 부활제

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

PC4A Registration of transfer of a eurasian patent by assignment